Money Strategic view: Jim Cramer on Howmet Aerospace: “It’s Just in The Sweet Spot” Strategic implications in focus: Jim Cramer discusses the promising outlook for Howmet Aerospace. editorial-staff Mar 8
Money Strategic view: Jim Cramer on AeroVironment, Inc.: “It’s a Long-time Cramer Fave, But Things Don’t Seem Right Here” Strategic implications in focus: Jim Cramer expresses concerns about AeroVironment, Inc., despite its long-standing popularity. editorial-staff Mar 8
Money Strategic view: Heatwaves driving recent ‘surge’ in compound drought and heat extremes Strategic implications in focus: Drought and heatwaves occurring together – known as “compound” events – have surged across the globe. editorial-staff Mar 6
Money Strategic view: Oil derivatives signal traders see Middle East shock as short-lived Strategic implications in focus: Traders anticipate a brief impact from recent Middle East tensions on oil markets. editorial-staff Mar 6
Money Strategic view: How oil price shocks ripple through your wallet, from gas to groceries Strategic implications in focus: Understanding the impact of oil price fluctuations on everyday expenses. editorial-staff Mar 6
Money Eutelsat's $5.8 Billion Refinancing: Strategic Move Amid Connectivity Challenges Eutelsat's recent €5 billion refinancing plan reflects a decisive strategy to enhance satellite capabilities and address European connectivity needs. editorial-staff Mar 6
Money Strategic view: DeBriefed 6 March 2026: Iran energy crisis | China climate plan | Bristol’s ‘pioneering’ wind turbine Strategic implications in focus: An essential guide to the week’s key developments relating to climate. editorial-staff Mar 6
Money Public Tracking of NASA's Artemis II Mission: A Strategic Move NASA's decision to allow public tracking of the Artemis II mission reflects a strategic approach to engage stakeholders in lunar exploration efforts. editorial-staff Mar 6
Money Strategic view: STAT+: Up and down the ladder: The latest comings and goings Strategic implications in focus: From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. editorial-staff Mar 6
Money Strategic view: FDA's Controversial Actions Against UniQure Raise Political Concerns Strategic implications in focus: Recent FDA decisions could complicate the Trump administration's relationship with drugmaker UniQure. editorial-staff Mar 6
Money Strategic view: Tracking Implementation of the 2025 Reconciliation Law: Medicaid Work Requirements Implementation Questions Strategic implications in focus: A list of the implementation questions relating to the Medicaid work requirements in the 2025 Reconciliation law. editorial-staff Mar 6
Money CSF Welcomes New Members Amid Growing Commercial Space Sector The Commercial Space Federation's recent membership expansion reflects strategic positioning in the evolving commercial space landscape. editorial-staff Mar 6
Money Strategic view: Q&A: What does China’s 15th ‘five-year plan’ mean for climate change? Strategic implications in focus: China’s leadership has published a draft of its 15th five-year plan setting the strategic direction for climate initiatives. editorial-staff Mar 6
Money NASA's Hygiene Protocols in Microgravity: A Tactical Perspective NASA astronauts' grooming practices aboard the ISS highlight the complexities of maintaining hygiene in a microgravity environment, impacting overall mission efficacy. editorial-staff Mar 6
Money Cygnus XL Completes Cargo Mission: Implications for NASA's Supply Chain The successful delivery of over 11,000 pounds of cargo by Cygnus XL highlights Northrop Grumman's operational reliability for NASA's ISS missions. editorial-staff Mar 6
Money Moderna's Strategic Shift Towards Oncology: Implications Ahead Moderna's pivot to oncology reflects broader trends in biotech, with potential risks and opportunities for investors and stakeholders. editorial-staff Mar 6
Money Robinhood's $658 Million Fund for Retail Investors: A Market Disruption? Robinhood's public offering of a $658 million private markets fund may reshape retail investment dynamics, but risks and implications warrant scrutiny. editorial-staff Mar 6
Money Servier's $2.5 Billion Acquisition of Day One: Strategic Implications Servier's acquisition of Day One Biopharmaceuticals for $2.5 billion could reshape its position in the pediatric oncology market, but risks remain. editorial-staff Mar 6
Money Strategic view: FDA-UniQure Tussle and Pfizer's Obesity Drug Approval in China Strategic implications in focus: China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded. editorial-staff Mar 6
Money Global Warming Rate Nearly Doubles, Paris Agreement at Risk The latest findings reveal that the rate of global warming has accelerated significantly since 2015, posing a serious risk to the Paris Agreement's 1.5C target by 2030. editorial-staff Mar 6